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Introduction 
Perinatal substance use continues to be a major public health issue in women’s health. The 
purpose of this study was to determine the frequency of substance use screenings in care and 
assess how well the existing services in Marin County are serving the needs of pregnant and 
parenting women and identifying the gaps and/or weaknesses in current practice. 
 
Methods 
Data for this study was collected via semi-structured interviews with five professionals that 
worked at the local community clinic, hospital and a non-profit agency. Some questions were 
slightly modified to be configured toward the participant’s specific profession. 
 
Results 
Results from the interviews reveal common screening practices though some were less formal 
and more conversational and there is no technical universal screening tool used. Participants also 
noted several common themes in gaps of care, in terms of patient’s views toward health care, 
needed improvements, common substances seen, the difference between the hospital and clinic 
protocol, adolescents, and African Americans.  
 
Discussion 
Findings suggest more training and a cohesive approach to screening should be implemented for 
both hospital and clinic settings. More understanding is needed for other care physicians as well 
as a need to address the gaps in care for the younger adolescent population, African Americans, 
and changing the negative perception of healthcare maternal patients have toward them. 
Examining other social determinants of health are also future implications to consider in 











Background & Problem Statement 
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Substance use during pregnancy presents multiple adverse health effects on both the 
mother and the fetus. Not only does it have detrimental effects on the mother’s health, the fetus 
is much more susceptible to long-term or irreversible damage in their development. The 
Diagnostic & Statistical Manual of Mental Disorders (DSM-5) defines substance use disorder as 
“when the recurrent use of alcohol and/or drugs causes clinically and functionally significant 
impairment, such as health problems, disability, and failure to meet major responsibilities at 
work, school, or home (Burns, Coleman-Cowger, & Breen, 2016).” In Marin County, a very 
affluent area, the prevalence of substance use in pregnant women has escalated over the years, 
resulting in harmful effects to women and their fetus. Limited resources are available in Marin to 
help mothers receive assistance and treatment with their substance use disorder(s).  
It is widely accepted that substance use is discouraged during pregnancy, and women are 
encouraged to seek abstinence while pregnant to provide the best childcare for their babies’ first 
year (Prince & Ayers, 2019). Only a minor portion of the pregnant population with substance use 
issues are identified and treated (Burns, Coleman-Cowger, & Breen, 2016). The most commonly 
used substance in pregnancy is nicotine, followed by alcohol, marijuana, and cocaine (Forray, 
2016). Vaping is a newer method of nicotine use that has been presumed to be less harmful than 
cigarette smoking, although most attitudes think the risk is not worth it for such a vulnerable 
population. The continued use of such substances can lead to poor pregnancy and neonatal 
outcomes, specifically increased risk of long-term physical, cognitive, behavioral, and academic 
problems for children (Muhuri & Gfroerer, 2009). Attitudes about substance use during 
pregnancy have varied across medical providers and mothers.  
Cannabis 
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Cannabis is the most commonly used illicit drug in the US and is the only substance that 
has seen significant increases in consumption and prevalence of use in the past decade (Emery, 
Gregory, and Levin, 2016). It is the third most commonly used substance during pregnancy 
following tobacco and alcohol (Emery et al, 2016). For the mother, there has been an association 
between perinatal marijuana use and pregnancy complications such as shorter gestation, 
dysfunctional labor period, preterm birth, low birth weights, and stillbirth (Holland, Nkumsah, 
Morrison, Tarr, Rubio, Rodriguez, Kraemer, Day, Arnold, & Chang, 2017). For the fetus, there 
are neurobehavioral consequences that can follow such as cognitive, learning, and behavioral 
problems which can lead to hyperactivity, attention problems, memory, and difficulty with 
reading and spelling (Holland et al., 2017). Although there have been adverse consequences, 
research is still limited in some areas regarding marijuana use during the perinatal period. The 
recent legalization of marijuana in several states over the past few years has likely influenced 
many user’s attitudes about its use and find it harmless.  
Most pregnant women perceive use of the drug once or twice per week to be of little to 
no risk (Scheyer, Melis, Trezza, & Manzoni, 2019). In one observational study, women also 
reported that though they received regular obstetric care, they did not receive any helpful 
information about perinatal marijuana use from health care providers or social workers 
(Jarlenski, Tarr, Holland, Farrell, & Chang, 2017). Because of this, most women stated that they 
conducted their own Internet searches for information about perinatal marijuana use and 
watching videos (Jarlenski et al, 2017). The lack of information did not bother some women 
because some indicated that they had stopped smoking marijuana once they found out they were 
pregnant, while others assumed that the providers and social workers did not provide adequate 
counseling. This made mothers feel as if marijuana was not a significant concern for the outcome 
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of their pregnancy or that it implied its use was not a serious risk (Jarlenski et al, 2017). Mothers 
also felt resentment toward social workers because the workers were more focused on child 
welfare agencies potentially being involved after the delivery of the baby instead of providing 
resources to help women stop using marijuana during pregnancy. This indicates a representative 
population of women who take initiative in receiving appropriate care, but not feeling that their 
care was fulfilled to prevent use of something they perceive as potentially harmful. Providers and 
social workers may not emphasize or educate their clients enough about the importance of not 
indulging in the illicit substance.  
 
Alcohol 
Alcohol is the second most used substance during pregnancy and no amount is considered 
safe during pregnancy (Roozen, Peters, Kok, Townend, Koek, & Curfs, 2018). The US 
Substance Abuse and Mental Health Services Administration (SAMHSA) noted in a recent study 
that about 5% of entries for treatment services were utilized by pregnant women with low 
numbers of them with alcohol issues and higher numbers for other drug uses (Burns et al., 2016). 
Drinking alcohol during pregnancy places the fetus at risk for birth defects, growth impairment, 
developmental disabilities, and neurodevelopmental dysfunction (Burns et al., 2016). Fetal 
Alcohol Spectrum Disorder (FASD) is a common condition that can affect the fetus for mothers 
who use, and can lead to poorer mental health outcomes. The severity of FASD depends on the 
level, pattern, and timing of prenatal alcohol exposure before and during pregnancy as well as 
diet, environmental, maternal age, and genetic makeup factors (Roozen et al., 2018). A study in 
Western Australia found that the use of provided educational resources for health professionals 
to their patients about prevention of prenatal alcohol exposure, consequences, and FASD was 
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effective in their use (Payne, France, Henley, D’Antoine, Bartu, O’Leary, Elliott, & Bower, 
2011). Of those interviewed, 69.8% had seen the materials, 77.1% used them, and 48.5% said the 
materials helped to change their practice or intention to change their practice (Payne et al., 2011). 
Altogether, 91.5% of the health professionals in the study agreed that drinking 5 or more 
alcoholic drinks on one occasion would harm the fetus. Ultimately, the study proved that health 
professional’s knowledge increased with the use of the materials and change in attitudes 
surrounding FAS and advice they give to pregnant women about consuming alcohol. In 
Australia, most providers in a particular study (88.1%) believed that pregnant women should 
avoid alcohol and those planning to become pregnant in the future should abstain (78.2%) 
(Payne et al., 2011). 
There are several screenings that providers are recommended to use to screen their patients, 
including the Cut Down, Annoyed, Guilty, and Eye Opener (CAGE) and Alcohol Use Disorders 
Identification Test (AUDIT) (Prince & Ayers, 2019). These were general screening tools that 
were not specified for pregnant patients, therefore an obstetrician developed the T-ACE/T-
ACER-3 and it was validated by the American College of Obstetricians and Gynecologists 
(ACOG) as well as the National Institute on Alcohol Abuse and Alcoholism. The obstetrician 
based the T-ACE on three questions assessing a patient’s annoyance with criticism of her 
drinking, her requirement of eye openers, and her alcohol tolerance (Prince & Ayers, 2019). The 
CDC also recommends using the Behavioral Risk Factor Surveillance System (BRFSS) to assess 
alcohol use among pregnant women (Burns et al., 2016).  
Vaping 
Electronic cigarettes (“e-cigs”) also known as vaping, have become increasingly popular as 
smoking rates have decreased. Traditional cigarette smoking during pregnancy is linked to 
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increased risk of miscarriage, cleft lip/palate, premature birth, and SIDS following birth 
(Whittington, Simmons, Phillips, Gammill, Cen, Magann, & Cardenas, 2018). The development 
of newer electronic nicotine delivery systems (ENDSs) are newer tobacco products that were 
introduced to the US in 2007, including, hookah, vape pen, vaporizers, and electronic cigarettes 
(e-cigs) (Whittington et al., 2018), Overall perceptions of ENDSs for pregnant women and 
general smokers are that they are less harmful than traditional cigarettes, which has increased 
their motivation to quit traditional cigarettes or reducing cigarette smoking (Whittington et al., 
2018). One survey reported that of 252 OB/GYNs, fewer than 53% consistently screen patients 
for exposure to tobacco products, which may contribute to the reasons that there are limited 
research on the effects of vaping (Whittington et al., 2018). 
Participants that posted in an online forum discussing nicotine use thought symptoms of 
nicotine withdrawal by pregnant mothers cause too much stress and that abrupt cessation is 
unsafe and unhealthy for women and their babies (Wigginton, Gartner, & Rowlands, 2016). 
Harm reduction is necessary, and posters within the forum thought that providers should enforce 
and emphasize this more in care. They also viewed vaping as less harmful and safer and that it 
could be managed by the smoker (mother) to be able to eventually cease use. Ironically, medical 
practitioners were described as supportive of vaping per their own personal claims (Wigginton et 
al., 2016). 
Attitudes Surrounding Substance Use 
Provider and Maternal Perceptions 
It is critical that medical professionals receive appropriate and competent training in 
screening patients. One study (Oser, Biebel, Harris, Klein, & Leukefeld, 2011) showed that 
gender difference had an influence on OB/GYN’s screening practices, with female practitioners 
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more likely to believe in the effectiveness of screening and discussing sensitive topics with 
patients, and motivated to provide screening as a part of care because they believe screening 
could produce a behavioral change. Another study highlighted how obstetric providers were not 
familiar with risks of marijuana use in pregnancy, perceived marijuana to not be as dangerous as 
other illicit substances, prioritized other counseling topics, and mentioned a need for more 
information and training on addressing perinatal marijuana use overall (Holland, Nkumsah, 
Morrison, Tarr, Rubio, Rodriguez, Kraemer, Day, Arnold, & Chang 2016). When and if 
providers did counsel patients on use, their primary approach was the legal consequences or 
involvement of child protective services, which may explain many patients’ fears to disclose 
their substance use status (Holland et al., 2016). Another reason that may explain the 
underrepresentation of mothers disclosing their use status is from mothers who reported they felt 
guilty and remorse of use and the fear of the loss of their children out of home care (Burns et al., 
2016). Women also reportedly have many perceived concerns and/or risks in disclosing their 
substance use, specifically feeling embarrassed and guilty about use, fearing imprisonment, 
prosecution, or losing custody of their child/children (Chang et al., 2018). Prior research suggests 
that pregnant women with substance use disorder(s) consider testing and reporting of their use to 
be punitive rather than potentially helpful or resourceful (Jarlenski et al., 2017). These 
implications altogether portray mothers’ legal concerns and of the repercussions, stigma, shame, 
and fear of being viewed as a “bad mother” as well as a need to address women’s mental health 
regularly during pregnancy to ensure she is supported. 
Recommendations/Treatments 
Healthcare professionals are a significant contributor to the concept of harm reduction 
especially within the realm of alcohol consumption for pregnant women. They are considered to 
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be the best source of information and should have expert advice especially during the perinatal 
period, therefore should be prepared with effective education materials (Payne et al., 2011). The 
ACOG and the American Academy of Pediatrics recommend that clinicians caring for pregnant 
women ask their patients at their initial prenatal visit about their drug use and provide education 
(Chang et al., 2017). The questions they ask should be presented in a nonjudgmental manner, to 
increase trust that is needed to obtain an accurate history and to retain mothers for ongoing care 
(Burns et al., 2016). The World Health Organization (WHO) recommends engaging women in 
improving their mental health before becoming pregnant since women are at the highest risk of 
substance use disorders during their reproductive years and mental health problems are most 
prevalent at childbearing ages (Prince & Ayers, 2019). This ensures women will achieve 
psychiatric stability and reduces negative mother and fetus outcomes. A study found that an 
integrated care approach for mothers resulted in many finding the environment safe and 
welcoming which allowed them to be more forthcoming about their issues and establish trust 
with providers, more access to care, women felt supported, and program engagement and rapport 
increased (Marcellus, MacKinnon, Benoit, Phillips, & Stengel, 2015).  
Additionally, OB/GYN’s should be advocates for patients and education for not only patients 
but also providers is necessary to continue with the unknown, yet possible harmful effects of 
ENDSs and to help prevent fewer toxins being exposed to fetus and mom (Whittington et al., 
2018). Though clinical evidence suggests that e-cigs are safer than smoking, there are still many 
concerns surrounding long-term effects for fetal development and online forums suggested that 
women refrain from them altogether (Wigginton et al., 2016). Pregnant women using cannabis 
should be offered support for cessation and relapse prevention at each prenatal visit throughout 
pregnancy (Burns et al., 2016). Asking a mother about her perceived level of severity can create 
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discussion about other problematic areas such as trauma and abuse, with special attention to high 
risks, as well as brief intervention, counseling, education, and psychologically based treatment 
for dependency. The 5 A’s approach (Ask, Advise, Assess, Assist, and Arrange) is also a well-
known tool to use for cases related to tobacco use and is recommended by the United States 
Preventive Services Task Force (USPSTF) and the ACOG though more intensive interventions 
may be required (Burns et al., 2016). 
Supervised detoxification may be necessary for those with more severe alcoholism, likely 
as an inpatient (Burns et al., 2016). Many pharmacotherapies available for alcohol dependence 
are contraindicated for pregnant women, yet withdrawal can lead to fetal distress and/or death. 
There is a specific need to focus on psychological and social approaches with assertive follow-up 
throughout and post pregnancy (motivational interviewing). Patient-provider communication is 
essential to care, with other interventions including counseling by midwives, screening via 
nonmedical community workers, and multimedia and educational efforts aimed to improve 
knowledge (Forray & Foster, 2015). There is clear evidence of the negative effects of alcohol, 
tobacco, and illicit drug use being harmful during the perinatal period, though vaping and 
cannabis use still needs to be thoroughly researched.  
Agency Profile 
The County of Marin’s Department of Health and Human Services (HHS) is a 
government entity that strives to promote and protect the health, wellbeing, safety, and self-
sufficiency of all people in Marin. They are the largest department in Marin County and 
currently have four divisions: planning and administration, behavioral health and recovery 
services, public health, and social services.  
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The public health department features an executive staff that is led by the Director of 
Health and Human Services, a Behavioral Health and Recovery Services Director, a Social 
Services Director, and a Public Health Officer. The Department is situated at the Marin Health 
and Wellness Campus in San Rafael, which features a variety of services for the public including 
a community clinic, all in one location. It was funded from a master settlement agreement to 
address Marin’s most critical health needs. The Connection Center is the heart of the campus and 
is host to many of the programs and services provided to the community. It is known as the 
center point for health promotion, prevention activities, meetings, and contact information 
needed for other county services. There is a vast bilingual and multicultural staff who assist the 
public for case management, billing services, health insurance enrollment, referrals, and 
assistance accessing services. To address risk factors that affect health and quality of life, the 
Connection Center has educational materials in English and Spanish and LCD screens that 
exhibit topics that feature health-related activities. The topics were chosen via community focus 
groups and meetings as well as input from HHS staff.  
The Maternal, Child, and Adolescent Health (MCAH) Program is a subsidiary program 
under the County of Marin’s Family Health Programs.  The program develops prevention and 
early intervention strategies to promote the health of the women, infants, children, and 
adolescents of Marin County with a special focus on low-income and vulnerable populations. 
MCAH program staff is involved in outreach, advocacy, policy development, assessment, and 
program planning to increase access to family-centered, culturally-competent systems of health 
services. The agency is headed by a director and program coordinator. Within the department, 
there is the Women, Infants, and Children Program (WIC), Marin Family Connections, Child 
Health Disability Prevention (CHDP), CA Children’s Services (CCS), and the Childhood Lead 
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Poisoning Prevention Program (CLPPP). Each service aims to serve families by achieving equity 
for families and children to have access to the best services for a healthy, safe, and productive 
life. The Behavioral Health and Recovery Services unit also works closely with MCAH and 
provides resources to refer clients to behavioral health services to specialists such as clinicians 
and/or other therapists as needed.  
Project goals and objectives 
 Originally, the two main goals of this project were to identify gaps in the system of care 
for pregnant and parenting women with SUD’s in Marin and to develop an updated, specific 
resource directory for mothers/expecting mothers who are experiencing SUD’s and for 
service/clinical providers to use (Appendix A). The initial plan was to interview pregnant and 
parenting mothers, but proved to be tricky to conduct interviews. Ultimately, it was determined 
that professional providers within the wellness campus would be easier to outreach to and could 
have just as much thorough insight and experience with their patients. Conducting interviews 
were delayed due to the difficult impact of the coronavirus pandemic. Outreaching in 
conjunction with my preceptor to potential participants was delayed until the pandemic calmed 
down (around June), but five were able to be completed instead of the original 10-15 interviews. 
Though a draft of a resource directory was made and to be edited after interviews 
(Appendix F), it was saved on the fieldwork site computer and unable to be accessed due to the 
coronavirus pandemic and shutdown of the facility. Around mid-March, restrictions were put in 
place that prevented anyone from going to their workplace. There were also plans to create new 
and updated educational materials to be available on the wellness campus and within the clinic as 
a secondary goal but was also unable to access. The draft lists specific providers and agencies 
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that are known in Marin to assist with pregnant and parenting mothers. Due to its inaccessibility, 




The purpose of this project was to understand the prominence of screening for substance 
use in parenting and pregnant mothers in Marin County and the gaps in care mothers do not 
receive. For this project, a qualitative analysis was used to determine the frequency of substance 
use seen in screenings done by providers and staff perspectives on the issue. Another task was to 




Five healthcare professionals (perinatal case manager, substance abuse counselor, 
obstetrician, and two pediatricians) that worked at the local Marin Community Clinic and local 
organizations were purposefully chosen via purposive sampling from my preceptor’s 
recommendations. These recommendations were based on the relevance of the provider and staff 
experience because of their interests in women’s maternal health per the MCAH’s close work 
with them.  
Recruitment 
An introduction email (Appendix B) was sent to potential participants via the MCAH for 
the project and outlined the goals and purpose of the interview. Out of twelve participants that 
were emailed, two emailed back with contact information the same day and were interviewed. 
One of the participants additionally forwarded the email to seven other providers that were 
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knowledgeable about perinatal substance use in the community. Of those participants that were 
forwarded the introduction email, three were interviewed. Two participants had great 
connections within their organization and forwarded the original email. Phone calls were made to 
each participant as they provided them via email along with their availability. Due to the 
coronavirus pandemic and shelter at home orders from the state, participants that were emailed 




Semi-structured interviews were conducted via phone calls with a 12-question item 
survey for providers and staff to answer. The length and scheduling of interviews varied for 
provider’s availability and staff within a three week time frame. Interviews lasted an average of 
30-45 minutes per session. Purposive sampling was used to recruit participants based on the 
MCAH director’s close network and relationships with providers that often work together.  All 
providers listed references on other prospective participants during the interviews and often cross 
referenced each other.  
Measures 
A 12-item questionnaire (Appendix C) was created and used based on the influence of 
one study’s use of a questionnaire from a Washington Health Department that used a 10-item 
questionnaire (Oser, Biebel, Harris, Klein, & Leukefeld, 2011). Though the original article was 
inaccessible to use their specific items, questions were modified as described from Oser and 
colleagues’ (2011) measures section. The dependent variable was how regularly providers screen 
for substance use and if they do at all. The independent variables were motivations for 
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screenings, if they felt there were enough resources for perinatal substance use, and if screenings 
would help effectively promote a positive behavioral change for their patients.  
The interview tool used was modified with suggestions and authorized to use from the 
MCAH director. Ultimately, the questions were placed in order of focusing first on screening, 
then referral and motivational interviewing, and finally treatment resources. The questions were 
also edited to more open-ended questions to obtain significant data for each response. Responses 
were recorded via notes typed using Microsoft Word during the interview. After each interview, 
notes were highlighted to review themes and develop best practices in addressing substance use 
in pregnant and parenting mothers.  
 
Challenges 
Some of the challenges that arose were availability of the staff due to the coronavirus 
pandemic and shelter at home enforcement. There was also limited data received during some of 
the interviews due to different professions and their approaches in care based on their 
background. The quality of the answers from each question mostly were thorough and enough 
information was able to capture a satisfactory general depiction of the frequency of substance use 
in mothers who struggle. Resources were also provided and all participants stated what  they felt 
was missing or lacking and had some feedback and insight from other program methods and on 
what is needed in Marin. A codebook was created and dissected using the qualitative analysis 
software N-Vivo to interpret and find themes. 
Goals of the Interviews 
Some of the main goals of data collection were: 
1. To identify barriers in care for pregnant/parenting mothers with SUD's 
2. To determine the frequency of screenings from provider perspectives/protocols 
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3. To identify motivating factors that make providers conduct screenings 
4.  To identify resources needed in Marin for more maternal support 
 
Interview Results & Data Analysis 
Qualitative data analysis using the N-Vivo software platform grouped together several 
common themes that were identified. The definition for each theme (Appendix E) was used to 
group similar ideas and attitudes in order to identify major themes.Findings were summarized in 
identifying common screening protocols and addressing the gaps in care as well as resources 
currently available and needed within Marin. 
The top themes (Appendix D) that participants noted in identifying barriers and resources 
needed for mothers with SUD’s were necessary areas of improvement, review of screening 
practices and protocols done and more outreach to adolescents. All of the participants  mentioned 
areas of improvement that needed in care of pregnant and parenting mothers with SUD’s and 
within their own working systems, as well as a need to better serve African American mothers 
and have better universal screening practices. Few positive interactive experiences were 
reported, primarily only on what participants viewed what a positive interaction would be 
perceived as in their opinion.  
Emergent Themes 
Areas for Improvement 
Every participant had commentary on areas of improvement needed in their work 
environment as well as commentary on procedures and programs they wished to see in the 
community. One provider noted how they “would love to change how they help manage 
substance use in the neonatal, postnatal care period. Whatever they could do to help that would 
be very beneficial especially for the bonding time, also consider working closer with pediatrics 
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who helps check the baby, nursery, mother, etc.” The next provider mentioned she wanted to 
adopt an approach that other hospitals were using, where they “moved toward keeping mom and 
baby together for bonding. In the postpartum period, she is interested in wanting to know how to 
help mothers who have substance use disorder(s) and how more support could be provided to 
reduce stigma and provide better and more competent care for their issues as well as partner with 
other outside organizations to help” as well. Another significant barrier mentioned was that 
“programs should be more accessible programs for mothers with postpartum depression, because 
they are expensive and can be hard to access. More Spanish speaking groups should be 
considered.” The protocol in the clinic’s screening was addressed, with one provider stating they 
would “love to see the clinic ending the use of urine toxicology testing because it does not serve 
nor benefit patients” which also may contribute to stigma and pregnant/parenting mother’s 
resistance to treatment.  
One provider also mentioned that there was a lack of diversity as far as gender-based 
services, stating that there were “very male dominated treatment centers” which could also affect 
services. The same provider also mentioned significance in the “lacking support for transwomen 
and women experiencing homelessness” which could also explain more barriers to having 
accessible treatment in terms of socioeconomic and gender identity status.  
 
Screening Practices 
The AUDIT-C was the only main professional screening tool (SAMHSA) that formally 
addressed a specific SUD. Another provider disclosed that they followed the SAMHSA 
guidelines and memorized the NIDA-Modified tool to identify risky substance use in their adult 
patients. Verbal and conversation screening practices were accounted for and notated in all 
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participant responses, most clarifying they did not use a specific tool per say, but 
conversationally were able to screen their patients. Both pediatricians noted they used the 
HEADS assessment, which is tailored toward adolescents and focused on the least threatening 
topics then later getting to more sensitive topics. 
 
Adolescents 
Three participants noted the lack of care and support in addressing adolescent audiences 
and prenatal care. Two participants were unsure of the full scope of OB/GYN practices since it 
was not their field of medicine. Both providers also believed “meeting adolescents where they 
were at” was essential to help in screening, specifically with the use of wellness centers that were 
available on campus at one local high school. The same participants also mentioned the local 
teen clinic “Huckleberry Youth Programs” that primarily serves adolescents was a huge indicator 
of support and positive response in decreasing SUD’s and pregnancy in younger teens. 
Huckleberry’s mission is to educate, inspire, and support underserved youth to develop healthy 
life choices, to maximize their potential, and to realize their dreams (Huckleberry, 2020).  
Common Substances Used 
All participants provided  substances that they commonly seen or have come across 
during their professional years in dealing with patients. There appeared to be a consensus of 
marijuana, tobacco, and alcohol being the most common substances mothers disclose that are 
mentioned during care. As one participant stated, “the most common ones that patients disclose 
willingly are alcohol, tobacco and marijuana. Patients say during pregnancy occasionally they 
have had alcohol and tobacco. Some patients say before pregnancy they were using alcohol or 
smoking but quit once they found out they were pregnant.” This suggests differences in opinion 
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that mothers perceive the potential harm and effects that substances have on the mother and their 
fetus. 
 A participant noted how younger audiences perceived substance use during pregnancy 
and stated how “pregnant teens perceive drinking during pregnancy is bad. Instead, they vape or 
orally take THC thinking that it is safer” which may contribute to differences in opinion across 
age groups. Participants hinted at the point that the legality of marijuana during recent years may 
have also decreased stigma towards its use even for mothers. Only one participant mentioned 
that “they do not screen for drugs unless the client shares that with them.” 
One participant noted that there was a change in recent years, where “meth and heroin 
were past issues that were prevalent previously.” Another participant also commented similarly 
saying “meth and opioids are the most common ones for illegal ones bought on the street but it is 
not as much of an issue as other less harmful substances.” Methamphetamine, cocaine, heroin, 
and fentanyl were uncommon and were often referred to outpatient services when it was 
previously a prevalent issue within the maternal population.  
 
Negative Perception of Healthcare 
Almost all providers were aware of and contributed to their reasoning why mothers do 
not seek assistance with their SUD’s or help overall for treatment. One provider noted that the 
“healthcare does not promote harm reduction or well-being enough. They too heavily focus on 
punishing and penalizing people.” Another professional discussed the child welfare systems and 
how they “make it challenging to conduct screening and have good conversations about 
substance use. Many people have distrust in the healthcare system because of it” especially for 
vulnerable populations. The main barrier addressed that three providers discussed was stigma 
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around substance use, which was very huge. One health professional mentioned that “lots of 
pregnant people that are using are aware of how stigmatized they will be and are fearful of being 
judged, being a bad mother/parent, being seen as the opposite of what a good mother is and that 
there is just lots of pressure for moms, which keeps them from wanting to disclose their SUD or 
substance use status altogether.” 
 
Hospital vs. Clinic Environment 
Some positive impressions were expressed over the clinic’s services than the hospitals. 
Two providers  mentioned the clinic has “great communication and referrals often are made 
within the clinic” and how they have a “robust behavioral health department connecting patients 
to the behavioral health team.” 
Evidently, there were several inconsistencies made between the hospital and clinic 
environment regarding protocols and patient care. One provider mentioned the difference, that 
“at the hospital, OB/GYNs are all over the place with screening, because they “know” their 
patients, whereas MCC has one protocol.” Similarly, the next professional mentioned that “she 
works at the hospital and during pregnancy there is heterogeneity within the OB/GYN providers 
because some are testing and following the recommended guidelines, but some are not. She has 
seen at-risk women go to OB/GYN practices and not be screened for drugs at all.” Another 
professional mentioned how “MCC has a very diverse environment in terms of patients and who 
they serve but separate from the hospital because the hospital is an unjust environment and 
features a lot of benefits for wealthy white patients, while patients on Medi-Cal or Medicare do 
not receive the same benefits.” Bias appears to be significant and evident in terms of the 
differences between the hospital and clinic from professional perspectives.  
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African Americans 
Consensually, three participants mentioned that the African American community was 
not properly served in Marin, especially in healthcare. One person mentioned that “the system 
disproportionately targets people of color, especially black people and indigenous persons.” 
Another informant noted the significance of having a leader or someone representative of your 
own group. The explanation was that “there is likely a lack of care especially for black patients 
because few providers are not a reflection of them, which leads to lack of trust. That is a long-
term hurdle and negative issue that the clinic and hospital have in serving them in Marin and 
why they likely are not served as well.” People of color in Marin have long experienced 
discrimantion and more needs to be done to provide patient-centered care and ensure 
competency training continues.  
 
Discussion & Implications  
Altogether, providers should be competent in care for mothers with SUD’s just as much 
as any other patient. Cultural competency training should continue and be visible as the resource 
directory already has implemented. Mutually, all participants gave insight on a need for a 
universal screening protocol and an interest in more training and understanding more patient-care 
approaches to addressing the subject with patients. A genuine interest and curiosity in 
progression and improvement in care was apparent, and an interest in the effects of vaping was 
also common.  The more common substances such as marijuana and alcohol appeared to be the 
most common substances that professionals encountered in the pregnant and parenting mother’s 
population as well as a need for more services. It was noted in two providers that in previous 
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years, for other common illicit drugs such as methamphetamine and heroin were prominent 
substances abused but has lessened over the years, which was a positive outcome. Two providers 
also alluded to other factors such as trauma and domestic violence and how they may coincide in 
terms of substance abuse and women’s health. It could also attest to how those factors address a 
need for necessary care needed for women with those struggles, especially in mental health. 
Those interested in women’s health and maternal care would benefit from this study’s purpose 
and reviewing the need for their populations and how to be proactive in discussing this with 
women. 
Patients and their providers should be able to maintain a solid foundation and relationship 
which would help continuity of care and a better perspective overall with the healthcare system. 
Trust and rapport with a provider are also significant factors for mothers with SUD’s to continue 
care to reduce those stigmas of being a bad mother, fear of losing custody of their children, 
embarrassment and guilt, or being fearful of punitive repercussions (Burns et al., 2016). Gender 
and identity should also be considered, though a couple of participants noted the fact that there 
was a lack of diversity as far as people of color and male versus female dominated treatment 
centers. Only two participants mentioned the use of a formal screening tool (AUDIT-C and 
NIDA) with one being used as an incentive for insurance purposes and the other being used 
through their training. More SAMHSA guidelines should also be considered for practice in 
healthcare and counseling sessions. Future studies could show the significant changes in care 
after professionals are educated on different screening tools then a follow up interview on how 
effective the tool(s) are or if they ended up adopting one. 
Some of the strengths of the study were having providers that work concurrently within 
the hospital and clinic and having providers with a dual perspective in each environment. Not 
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only were they familiar with the procedures for each, they also were familiar with the systems 
that other healthcare professionals engaged in and did not hold to a higher standard.  Having a 
concrete concept on the differences between care in the hospital and clinic is also vital for the 
possibility of integrated health models. Cultural competence training was also included in the 
directory in terms of the provider having completed training or not. Cultural competency training 
increases awareness and knowledge on topics on diversity and inclusion.  Having this displayed 
on a resource may also increase a mother's faith that their care is being treated by a professional 
who appreciates them without judgment or bias. 
Some of the limitations of this study were not interviewing male providers and health 
professionals, as well as not interviewing primary care physicians. Another limitation was not 
having designated questionnaires for each provider (OB/GYN, counselors, social workers, etc.). 
Another good population that would have been a good idea to interview and have a tool for 
would be primary care physicians (PCP) specifically for those who see parenting mothers that 
are already raising their children and/or expecting to have more children. This would gage 
attention towards the mother’s use and view the protocol done by PCP’s for screening and 
assistance. Purposive sampling was used to recruit participants based on the MCAH director’s 
close network and relationships with providers that often work together and to focus the project 
on clinical and service providers. Purposive sampling is when a researcher relies on his or her own 
judgment when choosing members of a population to participate in the study. 
For this study, no staff from rehabilitation and treatment centers were interviewed. A 
clinical perspective would have given more insight on treatment. More specifically, the Marin 
Treatment Center and Center Point were both mentioned by three providers as follow up services 
that they were aware of available for women. Center Point would have been a good resource of 
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information especially because one of their programs focuses on women and children. Per their 
website, “70% of the women remained employed and reunited with their families following 
completion of the program; over 90% remained abstinent and free of child welfare involvement; 
over half had regained custody of their minor children; and more than 85% were employed and 
had secured stable housing (CenterPoint, n.d).” Some of these other social determinants of health 
should be considered and used in future studies as well. Because of the impact of the 2020 
coronavirus pandemic and stay at home orders, the study was presumed to be limited to essential 
workers but providers were unavailable due to busier schedules and likely adjusting to the new 
norm from the mandates. Having a perspective from mothers would also likely have created a 
better snapshot of support needed and a perspective on their end of healthcare and their 
experiences.  
Another limitation was that providers were all female and it was a very small population 
of participants to interview. Due to the timing and because of COVID-19 as well as state and 
local restrictions, it was understandably a struggle to recruit participants and added to having 
some limited results. Having a more variety in other health professions that often deal with the 
pregnant and parenting mothers' population may have presented an array of other issues and 
barriers to address as well as more ideas for improvement and organizations to consider or 
implement in Marin.  
Recommendations 
In terms of screening, there are many recommendations the pediatricians expressed that 
their universal screening is incorporated and universal with younger teens, therefore could be 
merged into one question.  Marin needs to promote further education that should continue to be 
displayed and placed at the forefront of prenatal care and screenings should be universal to 
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incorporate a holistic approach. An adult version of the HEADSS assessment should also be 
considered to implement in pre- and post-natal care. To decrease stigma, attention should not 
solely be focused on the mother’s SUD(s) but her mental, emotional, and physical well-being. 
One participant noted that question 8 on the questionnaire about “programs that they wished 
were available” should be tailored to patients because they likely have a better perspective on the 
needs in their own community. This may likely positively correlate with a need for more support 
groups, whether in a physical or online forum format that should be considered for women to 
express their concerns and wishes for help.  
It is essential that other healthcare professionals be engaged in the severity of SUD’s 
within the pregnant and parenting mother's population and having a proper, universal method to 
assess and assist in their care. The ACOG and the AAP both recommend that clinicians ask their 
patients about their substance use at their initial visit, and should continue thereafter, especially if 
a mother shows more risks (Chang et al., 2017). Education on the potential risks and harms 
substances have on the fetus and the mother should be presented and reminded to patients at their 
prenatal appointments as well as assessing risks of the mother’s SUD’s and giving a warm hand 
off within the clinical setting as stated by current providers. SAMHSA currently offers a guide 
called the Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use 
Disorder and Their Infants that can be utilized during prenatal sessions and they also have 
suggestions on how to help treat mothers on various substances (SAMSA, 2020).  More training 
workshops should be held focused on substance use during pregnancy and the negative harms it 
has on both the fetus and the mother. Wellness training should also be considered for health 
professionals to target pregnant and parenting mothers and create a harm reduction approach in 
care for women. Group sessions or a local conference with local providers may present a 
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cohesive plan to create a universal screening approach that providers and counselors may find 
useful to implement in their practice setting. As previously stated, patient-provider 
communication is essential to this population to improve knowledge and education to help 
reduce the chances of use during pregnancy (Forray & Foster, 2015).  
Marin appears to be lacking in support and care for younger teens and mothers with 
SUD’s, as well as for women of color, especially African American women. Programs should be 
implemented in focusing on youth and policy should be focused on a universal approach for 
screening in both the clinic and hospital setting. Providers should be on the same page to 
maintain consistency in screening for both the pre- and post-natal period to reduce bias in their 
patient populations and consider having a more diverse workforce since that was a primary 
concern. Other professional and evidence-based screening tools, such as the 5 A’s or the BRFSS 
assessments should also be considered in Marin to determine the most effective and ways to 
determine a pregnant or parenting mother’s risk and SUD status to receive the best care possible 
that can be provided.  
Pregnant women experience many struggles mentally, physically, emotionally and 
socially with pregnancy. We cannot assume that all their issues are visible. With compassionate 
integrated care, proper screening protocols, resources, and support, we can help destigmatize 
mothers with SUDs and promote healthier outcomes for themselves and their children. 
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Appendix A: 





1. To identify gaps in the system of care for pregnant and parenting 
women with SUD’s in Marin.   
● By April, I will have contacted at least 10-15 providers that 
have direct perinatal specified services. 
● Create an interview guide 
○ Start & End Date: March 2020 
○ Tracking measure: create a list of questions that will 
be approved by preceptors 
● Email providers and schedule  phone interview 
○ Start & End Date: March 1-April 30th, 2020 
○ Tracking measure: book interview on a calendar 
● Ask questions conducive to new ideas surrounding services 
specifically for pregnant and/or parenting mothers  
○ Start & End Date: March 1-April 30th, 2020 






2.  To develop a specific resource directory for mothers/expecting 
mothers who are experiencing SUD’s and for service/clinical 
providers to use. 
● By the end of spring semester, I will have a completed 
resource/provider directory tailored to expecting or current mothers 
that are experiencing SUD’s 
● Create a draft of current resources available for moms 
○ Who is responsible: BW 
○ Start and End Date: January 31st-May 2020 
○ Tracking Measure: completed initial draft of current services 
● Integrate other local sources that may offer specified 
services/accommodations for moms  
○ Start and End Date: 
○ Tracking Measure: completed initial draft of current services 
Specific 
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● Create at least 2 updated educational pamphlets that mothers can 
use 
○ Start and End Date: January 31st-May 2020 
○ Tracking Measure: approval from SR/JS to be able to leave 






3. To learn about the frequency of screening substance use during the 
perinatal period for mothers in Marin.  
● By the end of spring semester, I will have learned about 
several screenings that providers use for mothers who abuse 
substances during and after pregnancy.  
● Attend at least three Maternal Child, Adolescent Health 
(MCAH) meetings for community perspective on maternal 
care 
○ Start & End Date: 2/1/2020-7/1/2020 
○ Tracking measure: maintain attendance record with 
SR 
● Conduct interviews with OB/GYN or other providers who 
screen mothers 
○ Start & End Date: 3/6/2020-3/27/2020 









Hi friends- we are very interested in improving the system of care for pregnant and parenting 
women who use substances.  Our fabulous intern, Breanna Williams, will be  conducting key 
informant interviews (by phone) with perinatal service providers to learn more about your 
screening practices and about the gaps that exist in the system of care. We would be very grateful 
if you could participate in a 15-20 minute phone interview in the near future.  
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Breanna's introduction: Hello, my name is Breanna Williams and I am a graduate student at the 
University of San Francisco. I am studying to receive my Masters in Behavioral Health and 
Public Health. I have been conducting fieldwork for my capstone due this August. I am currently 
working with the County of Marin Maternal Child & Adolescent Health program focusing on 
perinatal substance use in Marin. This interview should last about 15-30 minutes. You are 
welcome to skip any question you do not wish to answer and if needed, you are welcome to end 
the interview at any time. No identifying information will be provided in my report and will 
remain confidential. All the information provided will be used to understand the frequency and 
importance of screening, and to identify gaps in the system of care. 
1) Please contact Breanna cc'd above with your phone number and availability ASAP.  
2) Please forward this request to community partners or others within your agency whose input 
would be valuable, or send suggestions for people to include who might be involved in doing 
substance abuse screening and/or referrals for this population. 
3) We will make the findings available to all participants. 
Appendix C: 
Interview Guide  
Research Question: How regularly do providers screen for substance use in pregnant or parenting 
mothers and what conditions motivate them to? 
Key Informant Interview Questions: 
1. Do you routinely screen your patients for substance use? 
2. What prompts you to conduct a screening? What makes it challenging for you to conduct 
screening? (What specific concerns do you have about screening?) 
3. Do you use a screening tool? 
a. Yes: Which one(s)? 
b. No: Have you heard of CAGE, T-ACE, TWEAK, 4 P’s or considered using any 
of them? 
4. What are the most common substances that women screen positive for? What are the 
most common illegal substances that women are using? What are the most common 
substances women are voluntarily seeking treatment for? 
5. What are barriers to screening pregnant and parenting women for substance use in your 
setting? 
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6. Do you feel comfortable with motivational interviewing?  
7. What are some referrals and/or programs available that you refer pregnant women to? 
(can be local or further) 
8. Are there any other programs you wish were here in Marin to support mothers with 
SUD’s? (can be one you know, have seen, or found via research, word of mouth) 
9. Which populations are not well served by existing resources? (teens, non-English 
speakers, immigrants, low-income, POC, etc.) 
10. How does your organization address co-occurring disorders among pregnant women, 
such as depression, anxiety, suicidal thoughts, etc.? 
11. Is there anything else you’d like to contribute regarding perinatal substance abuse 
screening, referral, or treatment? 





















Name Description Files References 
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Adolescents anything pertaining to the 
adolescent group of 
women at childbearing 
age 
1 15 
African American any referral to Black 
Americans, ethnic group 
of Americans with total or 
some ancestry from any 
of the black groups in 
Africa 
1 4 
Areas for Improvement anything that was 
included that participant 
is interested in 
implementing, improving 
services and making them 
more accessible, services 
or protocols that should 
be provided or could be 
worked on for pregnant 




anything relating to the 
most common illicit or 
legal substances used, 
seen, or disclosed in 
screenings with pregnant 
and parenting mothers 
1 9 
Hospital vs Clinic 
Environment 
differences or similarities 
as far as protocol, beliefs, 
etc. in the hospital and 
clinic environment 
1 7 
Negative Perception of 
Healthcare 
anything related to the 
negative perspectives, 
beliefs, or experiences in 
healthcare that causes 
pregnant or parenting 
mothers less chance of 
seeking healthcare 
1 8 
Positive Interactions relating to the 
significance trust and 
rapport of building 
relationships with patients 
and what constitutes a 
good relationship with a 
provider 
1 8 
Screening Practices current practices or 















































































































































BAY AREA COMMUNITY RESOURCES 
Last Name 
 
First Name     License National Provider 
ID # 
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Coleman Michael Licensed 
Marriage & 
Family Therapist 
1356616684 A3006108 Yes 
 
Cosby-Frost Amy Licensed 
Marriage & 
Family Therapist 
1841218492 LMFT 42309 Yes 




1194114652 LMFT 14645 Yes 
Kantarowski Laura Psychologist 1992287122 PSY 7739 Yes 
Meneweather Leslie Associate 
Marriage & 
Family Therapist 
1740528645 AMFT 80280 Yes 











1770003071 R1214130915 Yes 




1700275104 Aii52480218 Yes 
Williams Dolores Licensed Clinical 
Social Worker 




Last Name First Name License National Provider 
ID # 








1992269930 R1335740119 Yes 
Breslin Alexandra Associate 
Marriage & 
Family Therapist 
1801374624 AMFT 113948 Yes 
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1831621879 8306 Yes 




1063793727 C14751214 Yes 




1871153536 R7454 Yes 











1053523803 8380 Yes 
Katz Stacey Licensed 
Professional 
Clinical Counselor 




























1376070440 R1269111117 Yes 




1285287854 R1347860519 Yes 




1336709054 R1358230810 Yes 




1427339365 Aii060440918 Yes 
Owens Rebecca Certified 
Substance Use 
1568749648 Aii059970618 Yes 
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Disorder 
Counselor 




1568900983 R1264730917 Yes 




1356621148 9919 Yes 
Smith Ada Licensed 
Marriage & 
Family Therapist 
1306067483 LMFT 15644 Yes 
Taylor Rodney Licensed 
Marriage & 
Family Therapist 
1588058697 LMFT 12402 Yes 
Taylor Sushma Licensed 
Marriage & 
Family Therapist 
1275927394 LMFT 24269 Yes 
 
MARIN TREATMENT CENTER 
Last Name First Name License National Provider 
ID # 








1821483454 R1302680418 Yes 




1932688033 R1323300918 Yes 
Catan Hope Associate 
Marriage & 
Family Therapist 
1427426527 AMFT 100862 Yes 
Diamond Joan Licensed 
Professional 
Clinical Counselor 
1023365392 LPCC 3239 No 




1699215608 R1295680318 Yes 
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1295944809 Ci1870315 Yes 
Laffey Rajena Registered 
Alcohol & Drug 
Technician  
1821640913 R1351840619 No 
Lee Yuen Licensed 
Vocational Nurse 
1639626757 VN275623 No 
Maillo Cabrera Juan Licensed 
Marriage & 
Family Therapist 
1306161617 LMFT 103938 Yes 
Moriguchi Ryoko Licensed 
Marriage & 
Family Therapist 
1811029713 LMFT 47591 Yes 




1609106608 N0312291432 Yes 
Obranovich Cherie Registered 
Psychologist 
1518389501 29613 Yes 
Ogg Aubrey Physician’s 
Assistant 
1245757194 54769 No 




1679000442 R1311800618 Yes 




1487710026 R1322440918 Yes 
Tocher Danielle Licensed 
Marriage & 
Family Therapist 
1962729772 LMFT 114138 Yes 
 
 
